| 摘要 |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention relates to field of pharmaceutics and medicine and deals with anticancer pharmaceutical composition or combination for prevention cancer of lungs or cancer of kidney, which contains as active ingredients medication, which is produced from gefitinib, erlotinib and soraphenib, and dihydrochloride 5-(4-(6-(4-amino-3,5-dimetylphenoxy)-1-metyl-1H-benzimidazol-2-ilmethoxy)benzyl)thiazolidine-2,4-dione. ^ EFFECT: invention insures increased efficiency of treatment. ^ 16 cl, 5 dwg, 3 tbl, 18 ex |
